B+
Bull case
0%
Probability
Target price
$150.00
+2.1% vs current
DCO
DucommunCNYSE / Capital Goods
Last Price
At close
2026-06-03
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
1%
Probability
Target price
$132.00
-10.2% vs current
B-
Bear case
0%
Probability
Target price
$118.00
-19.7% vs current
AI sentiment snapshot
Latest data as of 2026-05-03
Recent news sentiment (30D)
-0.3
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+37.6
Score
AI commentary
As of May 3, 2026, this looks more like an early or mistimed post-earnings follow-up than a true T+3 earnings read: Ducommun's company press release on April 28, 2026 said Q1 2026 results are scheduled for May 12, 2026, while the May 1, 2026 8-K introduced a negative accounting overhang before the quarter was reported. Immediate sentiment is therefore skewed by the restatement headline rather than by confirmed Q1 operating results, and I did not find a trustworthy post-print analyst revision set to upgrade conviction.
RankAlpha Sentiment Codex - 2026-05-03
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-12eventRestatement resolution and shifted Q1 reporting dateHigh impact
The highest-priority catalyst is not a normal post-earnings readout: on May 1, 2026 Ducommun said prior 2024-2025 financials should no longer be relied upon because of stock-comp timing errors, expects the restatement work to finish on or before May 8, 2026, and still expects to release Q1 2026 results on May 12, 2026. That means the queue date of April 30, 2026 appears stale, and the next real thesis test is whether the amended filing and Q1 release arrive cleanly and without wider revisions. [#8-K-2026-05-01] [#PR-2026-04-28]
2026-05-12catalystQ1 EPS optics face a stock-comp headwind even if cash economics are intactMedium impact
Management said the error was non-cash and did not affect historical net revenue, gross margin, or operating cash flow, but also said Q1 2026 will carry roughly $5.0 million to $6.0 million of higher stock-based compensation versus prior expectations. That setup can pressure near-term EPS framing and analyst revisions even if underlying operations are steadier than headline optics imply. [#8-K-2026-05-01]
2026-09-30catalystAerospace and defense exposure still supports the demand base if credibility is restoredHigh impact
Ducommun's FY2025 mix remained heavily tied to aerospace and defense, which represented 96% of revenue, with commercial aerospace alone at 38%, so the longer-term demand backdrop can still support orders if the company gets through the accounting reset without operational spillover. This is supportive, but it is a secondary thesis until reporting credibility is re-established. [#10-K-2026-02-26]
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-03 • Updated nightlySource: Internal modelMethodology